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مرض السكري خالل احلمل وما قبل احلمل عندالنساء العمانيات
مقارنة النتائج عند الوالدة وفرتة ما قبل الوالدة
عادل اأبوالهيجاء، ماجدة البا�ض، مرمي ماثيو
abstract: Objectives: The aim of this study was to assess the prevalence of gestational diabetes mellitus (GDM) 
and pregestational diabetes mellitus (PGDM) among pregnant women in Oman and compare their obstetric and 
perinatal outcomes. Methods: This retrospective study assessed the obstetric and perinatal outcomes of pregnant 
Omani women with GDM or PGDM who delivered at the Sultan Qaboos University Hospital in Muscat, Oman, 
between January 2009 and December 2010. Results: There were a total of 5,811 deliveries during the study period. 
Of the 5,811 women who gave birth, 639 women were found to have diabetes mellitus (11.0%). A total of 581 of 
the diabetic women had GDM (90.9%) and only 58 (9.1%) had PGDM. Women with PGDM had a significantly 
higher incidence of pre-eclampsia (P = 0.022), preterm deliveries (P <0.001) and Caesarean sections (P <0.001). 
Neonatal complications, such as respiratory distress syndrome (RDS), neonatal hypoglycaemia, neonatal jaundice 
and subsequent admission to a neonatal intensive care unit (NICU) were significantly higher for neonates born to 
mothers with PGDM compared to those born to mothers with GDM (P <0.001). The corrected perinatal mortality 
rates for women with PGDM and GDM were 34.5 and 13.7 per 1,000 live births, respectively. Conclusion: In this 
Omani cohort, women with PGDM were at higher risk of developing obstetric and perinatal complications such 
as pre-eclampsia, preterm delivery and Caesarean delivery compared to women with GDM. In addition, neonates 
who had mothers with PGDM had higher rates of RDS, neonatal hypoglycaemia, neonatal jaundice and admission 
to the NICU.
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الن�ساء احلوامل يف  )GDM( و�سكري ما قبل احلمل بني  انت�سار �سكري احلمل  الدرا�سة هو تقييم مدى  الهدف من هذه  الهدف:  امللخ�ص: 
عمان ومقارنة النتائج عند الولدة وفرتة ما قباللولدة. الطريقة: هذه درا�سة ا�ستعادية لتقييم نتائج الولدة وفرتة ما قبل الولدة للن�ساء 
اأو �سكري ماقبل احلمل يف م�ست�سفى جامعة ال�سلطان قابو�ض يف م�سقط، عمان، بني يناير  العمانيات احلوامل ممن لديهن �سكري احلمل 
2009 ودي�سمرب 2010. النتائج: كانت هناك 5,811 ولدة يف تلك الفرتة. من 5,811 امراأه ولدت يف امل�ست�سفى وجدت 639 امراأة لديها داء 
ال�سكري )%11.0(. منهن 581 كان لديها �سكري احلمل )%90.9(، و 58 فقط )%9.1( لديهن �سكري ماقبل الولدة. يف الن�ساء الالتي لديهن 
القي�رسية  والولدة   )P  >0.001( املبكرة  الولدة  وكذلك   ،)P  =  0.022( اإح�سائيا  اأكرب  بن�سبة  احلمل  ت�سمم  ح�سل  الولدة  ماقبل  �سكري 
الدم عندالأطفال حديثي  )RDS(، نق�ض �سكر  التنف�سية  ال�سائقة  الولدة، مثل متالزمة  ))P >0.001(. وكذلك كانت امل�ساعفات حلديثي 
اأمهاتهم  اأعلى بكثري للر�سع الذين كانت   )NICU( الولدة، والريقان الوليدي والدخول لحقا يف وحدة العناية املركزة حلديثي الولدة 
لديهن �سكري ما قبل احلمل مقارنة مع الذين اأمهاتهم لديهن �سكري احلمل. )P >0.001(. كانت معدلت الوفيات للر�سع ما حول الولدة 
للن�ساء الالتي لديهن �سكري ما قبل احلمل 34.5 وللن�ساء الالتي لديهن �سكري احلمل 13.7 لكل 1,000 ولدة حية، على التوايل. اخلال�صة: 
يف هذه املجموعة من الن�ساء العمانيات، كانت الن�ساء الالتي الالتي �سكري ما قبل احلمل اأكرث عر�سة مل�ساعفات الولدة مثل ت�سمم احلمل، 
الولدة املبكرة والولدة القي�رسية مقارنة مع الن�ساء اللواتي لديهن �سكري احلمل. بالإ�سافة اإىل ذلك، فقد كان لدى الر�سع لالأمهات الالتي 
لديهن �سكري احلمل ارتفاع يف معدلت متالزمة ال�سائقة التنف�سية، ونق�ض �سكر الدم يف لأطفال حديثي الولدة، والريقان الوليدي ومعدل 
الدخول اىل وحدة العناية املركزة حلديثي الولدة.
مفتاح الكلمات: مر�ض ال�سكري؛ �سكري احلمل؛ العناية ما قبل الولدة؛ التوليد؛ م�ساعفات؛ عمان.
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Advances in Knowledge
- From the results of this study, Omani women with pregestational diabetes mellitus (PGDM) are at higher risk of developing certain 
obstetric and perinatal complications in comparison to women with gestational diabetes mellitus (GDM).
- Neonates born to Omani mothers with PGDM had higher rates of respiratory distress syndrome, neonatal hypoglycaemia, neonatal 
jaundice and subsequent admission to a neonatal intensive care unit compared to those with GDM mothers. 
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Gestational diabetes mellitus (gdm)is defined as a carbohydrate intolerance which occurs for the first time during 
pregnancy and disappears by the end of the 
puerperium.1 If diabetes mellitus is diagnosed before 
pregnancy, it is classified as pregestational diabetes 
mellitus (PGDM). The reported prevalence of diabetes 
in Oman is approximately 12.0%, with the disease 
affecting males and females equally.2 Approximately 
3.0% of pregnant women in Oman develop GDM 
before delivery.3 In the United Arab Emirates, GDM 
has been reported to occur in 5.0% of pregnancies.4 
A mild increase in glucose levels during pregnancy 
can adversely affect both the mother and fetus. 
Increased incidences of pre-eclampsia, preterm 
delivery, miscarriage, fetal malformation and perinatal 
mortality and morbidity have been reported in diabetic 
pregnancies in comparison to the general population.5 
Hyperglycaemia during pregnancy is associated with 
macrosomia, which may subsequently lead to shoulder 
dystocia and birth trauma in addition to an increase in 
the rate of Caesarean sections.6 Additionally, research 
has shown that hyperglycaemia is associated with 
an increased risk of perinatal mortality and neonatal 
complications such as respiratory distress syndrome 
(RDS), neonatal hypoglycaemia and jaundice.7–9 
The majority of studies in the literature on this 
topic have compared the obstetric and perinatal 
outcomes of women with uncomplicated pregnancies 
to either PGDM or GDM cohorts. This study aimed 
to retrospectively review the obstetric and perinatal 
outcomes of women with PGDM or GDM who 
were cared for and delivered at the Sultan Qaboos 
University Hospital (SQUH), a tertiary hospital in 
Muscat, Oman.
Methods 
This retrospective study investigated the obstetric 
and perinatal outcomes of pregnant Omani women 
between 15–49 years old with GDM and PGDM 
who delivered at SQUH between January 2009 and 
December 2010. Patient records were retrospectively 
reviewed for maternal data (age, parity, gestational age, 
labour induction and mode of delivery), antenatal or 
obstetric complications (e.g. pre-eclampsia, preterm 
delivery, polyhydramnios or oligohydramnios) and 
perinatal outcomes (birth weight, five minute Apgar 
scores, admission to the neonatal intensive care 
unit [NICU], fetal anomalies, stillbirths and early 
neonatal deaths). Neonatal complications, such as 
RDS, neonatal hypoglycaemia and jaundice, were also 
reviewed. Women were considered diabetic (positive 
oral glucose tolerance test [OGTT]) if either their 
fasting or two-hour blood glucose levels (venous 
plasma glucose) exceeded 5.5 or 9 mmol/L (99 or 
162 mg/dL), respectively.
During the study period, standard SQUH protocol 
for the diagnosis and management of diabetes during 
pregnancy required that all healthy pregnant Omani 
women who were not known to be diabetic or at 
high-risk of developing diabetes undergo random 
blood sugar tests during their first official antenatal 
appointment (at between eight and 12 gestational 
weeks). If their blood sugar level was >7 mmol/L 
(126 mg/dL), then a two-hour 75 g OGTT was 
performed in order to diagnose PGDM. Pregnant 
women who were not known to be diabetic but were 
classified as having a relatively high risk of developing 
diabetes also underwent a two-hour 75 g OGTT during 
their first official antenatal appointment. Women were 
considered high-risk if they had a history of recurrent 
miscarriages, macrosomia, fetal malformation or 
unexplained intrauterine fetal death (IUFD) or a family 
history of diabetes, previous GDM or glycosuria on at 
least two occasions. For pregnant women who were 
not at an increased risk of developing diabetes, a 50 g 
oral glucose challenge test was performed between 24 
and 28 gestational weeks. If their blood sugar level was 
≥7.8 mmol/L (140 mg/dL), a two-hour 75 g OGTT 
was performed. 
Women with diabetes were treated with a diet plan 
and/or administration of metformin or subcutaneous 
insulin. Glycaemic control was considered satisfactory 
for patients with preprandial glucose levels of 
<5.5 mmol/L (99 mg/dL) and two-hour postprandial 
levels of <8 mmol/L (144 mg/dL). Long-term glycaemic 
control was assessed by estimating glycosylated 
haemoglobin levels; women with levels of <6.0% were 
considered to have satisfactory glycaemic control. The 
major indication for a Caesarean delivery included 
cephalopelvic disproportion (CPD) or 1–2 previous 
Caesarean section deliveries performed due to CPD. 
Statistical analyses were performed using Chi-
squared, Mann-Whitney U and Fisher’s exact tests, 
as appropriate. Differences between values were 
Application to Patient Care
- Pregnant diabetic women, particularly women with PGDM, should be monitored closely for obstetric complications. Any complications 
should be recognised and managed effectively so that they do not adversely affect perinatal outcomes.
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(25.9% versus 9.5%; P <0.001) and Caesarean sections 
(60.3% versus 27.9%; P <0.001) were also significantly 
higher in women with PGDM compared to those 
with GDM. There were no differences between 
the groups with regards to the incidence of other 
obstetric complications such as polyhydramnios, 
oligohydramnios or labour induction. The incidence 
of shoulder dystocia was the same in both groups.
The perinatal outcomes of women with PGDM 
and those with GDM are compared in Table 2. There 
were no significant differences in mean birth weight 
or the incidence of macrosomia or intrauterine 
growth restriction between the two groups. Neonatal 
complications such as RDS (8.5% versus 2.6%; 
P = 0.028), hypoglycaemia (6.8% versus 1.5%; P = 0.024) 
and jaundice requiring phototherapy (8.5% versus 
2.4%; P = 0.022) were significantly higher in babies 
born to PGDM women compared to their GDM 
counterparts. There was no significant difference 
in the incidence of fetal anomalies, intrapartum or 
unexplained IUFD, stillbirths with malformations or 
early neonatal deaths between the groups. More babies 
considered significant at P ≤0.0500. 
Ethical approval for this study was granted by the 
Medical Research & Ethics Committee of the College 
of Medicine & Health Sciences at Sultan Qaboos 
University (MREC #397). 
Results
During the study period, there were 5,811 deliveries. 
Of the 5,811 women who gave birth, 639 were diabetic 
(11.0%). Of these, 581 had GDM (90.9%) while only 58 
had PGDM (9.1%). All women with PGDM received 
insulin therapy. In the diabetic cohort, 42.0% of the 
women had had 1–2 previous Caesarean section 
deliveries performed due to CPD.
Table 1 compares the demographic characteristics 
and obstetric outcomes of women with GDM to those 
with PGDM. There were no significant differences 
in mean maternal or gestational age between the 
two groups. Parity was also not significant between 
the two groups. However, women with PGDM had 
a significantly higher incidence of pre-eclampsia 
compared to those with GDM (17.2% versus 7.8%; 
P = 0.022). The incidence of preterm deliveries 
Table 1: Demographic characteristics and obstetric 
outcomes of women with gestational diabetes and 
pregestational diabetes among a pregnant Omani 
cohort (N = 5,811)






Mean age in years 
± SD
31.6 ± 13.6 32.6 ± 5.9 0.579
Parity
0 134 (23.1) 14 (24.1) 0.871
1‒4 265 (45.6) 21 (36.3) 0.212
≥4 182 (31.3) 23 (39.6) 0.237
Mean gestational age 
in weeks ± SD
38.3 ± 2.1 38.6 ± 5.9 0.415
Obstetric outcome 
Pre-eclampsia 44 (7.8) 10 (17.2) 0.022
Preterm delivery at 
<37 gestational weeks
55 (9.5) 15 (25.9) <0.001
Caesarean section 162 (27.9) 35 (60.3) <0.001
Shoulder dystocia 10 (1.7) 1 (1.7) >0.999
Polyhydramnios 29 (4.9) 4 (6.8) 0.529
Oligohydramnios 4 (0.7) 1 (1.7) 0.380
Induction of labour 139 (23.9) 9 (15.5) 0.191
GDM = gestational diabetes mellitus; PGDM = pregestational diabetes 
mellitus; SD = standard deviation.
Table 2: Perinatal outcomes of women with gestational 
diabetes and pregestational diabetes among a pregnant 
Omani cohort (N = 5,811)






Mean birth weight 
in g ± SD
3,166 ± 597 3,135 ± 793 0.715
Macrosomia >4,000 g 29 (4.9) 6 (10.3) 0.120
IUGR 5 (0.8) 1 (1.7) 0.436
Birth weight <2,500 g 51 (8.8) 8 (13.6) 0.231
NICU admissions 75 (12.9) 18 (31.0) <0.001
RDS 15 (2.6) 5 (8.5) 0.028
Neonatal 
hypoglycaemia




14 (2.4) 5 (8.5) 0.022
Apgar scores <7 at 
five minutes
25 (4.3) 5 (8.5) 0.179
Fetal anomalies 11 (1.8) 2 (3.4) 0.333
Intrapartum IUFD 1 (0.2) 1 (1.7) 0.173
Unexplained IUFD 7 (1.2) 1 (1.7) 0.535
IUFD with 
malformations
3 (0.5) 1 (1.7) 0.317
Early neonatal death 1 (0.2) 1 (1.7) 0.173
GDM = gestational diabetes mellitus; PGDM = pregestational 
diabetes mellitus; SD = standard deviation; IUGR = intrauterine 
growth restriction; NICU = neonatal intensive care unit; RDS = 
respiratory distress syndrome; IUFD = intrauterine fetal death.
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born to mothers with PGDM were admitted to the 
NICU compared to those with GDM mothers (31.0% 
versus 12.9%; P <0.001). In women with GDM, 
obstetric and perinatal outcomes were not affected by 
treatment method.
The uncorrected perinatal mortality rate was 
significantly higher in women with PGDM compared 
to women with GDM (68.9 and 20.6 per 1,000 live 
births, respectively; P = 0.041). However, when this 
rate was corrected for lethal fetal malformations, the 
difference in perinatal mortality rates between the two 
groups was not significant (13.7 and 34.5 per 1,000 live 
births; P = 0.222). 
Discussion
Pregnant diabetic women have an increased risk 
of developing obstetric complications such as pre- 
eclampsia and preterm delivery and perinatal compli-
cations such as miscarriages and fetal malformations. 
These complications are observed more frequently in 
women with PGDM compared to women with GDM; 
this may be due to the prolonged and severe fetal 
exposure to hyperglycaemia.10,11 In the current study, 
the incidence of pre-eclampsia was higher among 
women with PGDM compared to women with GDM. 
These findings are in agreement with those from a 
recent Japanese study which reported an incidence 
of 10.1% and 6.1% for PGDM and GDM women, 
respectively (P <0.05).11 
Cetković et al. noted that adverse neonatal 
outcomes were common among women with PGDM; 
macrosomia occurred in 29.6% of infants born to 
PGDM women in their study.12 In contrast, the inci-
dence of macrosomia was much lower in the current 
cohort of women with PGDM (10.3%) and those with 
GDM (4.9%). This may be due to early diagnosis, strict 
glycaemic control and labour induction (providing 
that there was no contraindication for vaginal delivery) 
between 38 and 40 gestational weeks. 
In the current study, women with PGDM had a 
considerably higher occurrence of Caesarean sections 
and an increased risk of developing pre-eclampsia 
when compared to those with GDM. This may also have 
contributed to the higher rate of Caesarean sections 
among the PGDM women. Infants born to women 
with PGDM also had an increased rate of premature 
delivery (<37 gestational weeks) when compared to 
those born to GDM women. This may have been due 
to the relatively higher, but not statistically significant, 
incidence of polyhydramnios and fetal malformation 
in the PGDM group. Additionally, infants born to 
women with PGDM were admitted more frequently 
to the NICU, mainly because of RDS, neonatal hypo- 
glycaemia and neonatal jaundice requiring photo-
therapy. In women with GDM, obstetric and perinatal 
outcomes were not affected by treatment methods. 
This may indicate sufficient control of blood sugar 
levels during treatment.
The corrected perinatal mortality rate found in 
the current study did not differ significantly between 
women with PGDM and those with GDM. However, 
the PGDM mortality rate was lower than that reported 
by other studies, with perinatal mortality rates of 111.1 
and 66.2 per 1,000 live births in women with PGDM, 
respectively.12,13 In comparison, a Saudi Arabian study 
reported a similar perinatal mortality rate for women 
with GDM (13.6 per 1,000 live births).14 The relatively 
low GDM perinatal mortality rate observed in the 
current study may be due to strict glycaemic control 
and careful follow-up during pregnancy. 
Conclusion 
In the studied Omani cohort, women with PGDM had 
a higher risk of developing obstetric complications 
such as pre-eclampsia or experiencing preterm or 
Caesarean deliveries in comparison to those with 
GDM. Although the incidence of fetal complications 
such as RDS, neonatal hypoglycaemia and neonatal 
jaundice was significantly higher in women with 
PGDM, corrected perinatal mortality rates did not 
differ significantly between the two diabetic groups. 
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